Brennan Daniel J.'s Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 20, 2024
- Accession no.
- 0001225208-24-002571
- Filed
- Feb 20, 2024
- Trade date
- Feb 16-20, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $899.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brennan Daniel J.CIK 0001595612 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Common Stock | MOption exerciseAcquired | +4,243 | $0.00F1 | $0 | 268,812 | Direct | |
| Feb 16, 2024 | Common Stock | FTax withholdingDisposed | −1,882 | $65.82 | −$123,873.24 | 266,930 | Direct | |
| Feb 17, 2024 | Common Stock | MOption exerciseAcquired | +4,583 | $0.00F1 | $0 | 271,513 | Direct | |
| Feb 17, 2024 | Common Stock | FTax withholdingDisposed | −2,033 | $65.82 | −$133,812.06 | 269,480 | Direct | |
| Feb 18, 2024 | Common Stock | MOption exerciseAcquired | +3,706 | $0.00F2 | $0 | 273,186 | Direct | |
| Feb 18, 2024 | Common Stock | FTax withholdingDisposed | −1,644 | $65.82 | −$108,208.08 | 271,542 | Direct | |
| Feb 20, 2024 | Common Stock | MOption exerciseAcquired | +13,662 | $13.08 | +$178,698.96 | 285,204 | Direct | |
| Feb 20, 2024 | Common Stock | SSaleDisposed | −13,662 | $65.86 | −$899,779.32 | 271,542 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Common Stock | MOption exerciseDisposed | −4,243 | $0.00 | $0 | 8,486 | Direct | |
| Feb 17, 2024 | Common Stock | MOption exerciseDisposed | −4,583 | $0.00 | $0 | 4,584 | Direct | |
| Feb 18, 2024 | Common Stock | MOption exerciseDisposed | −3,706 | $0.00 | $0 | 0 | Direct | |
| Feb 20, 2024 | Common Stock | MOption exerciseDisposed | −13,662 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Referenced by the price of 2 transactions in Table I.
- F2
Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
Referenced by the price of 1 transaction in Table I.